Pneumonia
Invasive pneumonia, drug resistance lower after childhood vaccine introduced
Published in Medical Letter on the CDC and FDA, April 17th, 2005
The problem of increasing antibiotic resistance in cases of Streptococcus pneumoniae, a major cause of pneumonia, meningitis and sepsis, was dramatically reversed following the licensing and use of a new conjugate vaccine for young children in February 2000, according to research conducted at Emory University, the Atlanta Veterans Affairs Medical Center, the U.S. Centers for Disease Control and Prevention, and the Georgia Division of Public Health.
The researchers also found a significant decrease in the incidence of invasive pneumococcal disease in both vaccinated children and unvaccinated adults after the vaccine was introduced.
The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Anthrax
Beefed up vaccine makes for a stronger and faster immunoglobulin response - Diet and Nutrition
Obesity does not play a role in vitamin D differences in black and white women - Ebola Virus
Recombinant Zaire ebola virus is effective for screening antiviral compounds - Tuberculosis
Scientists study the basis of resistance to capreomycin - Virology
Researchers describe four new enteroviruses - Advocacy
Abuses against women still rampant in Africa, NGO says - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
